Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Anybody actually read the financials???

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Feb 08, 2023 2:55pm

176 Views

Post# 35275218

RE:RE:RE:RE:Anybody actually read the financials???

I am a very long time holder of SVA.
Why is a US company worth $1B having only one drug in its pipeline for lower back pain.
While we are only valued at $333M having such an amazing functional cure for Diabetes and Thyroid disease.
We should easily reach $1B once its pouch is approved by FDA.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for May 22, 2024